Cargando…
Cardiovascular Manifestations and Management in ADPKD
Cardiovascular disease (CVD) is the major cause of mortality in autosomal dominant polycystic kidney disease (ADPKD) and contributes to significant burden of disease. The manifestations are varied, including left ventricular hypertrophy (LVH), intracranial aneurysms (ICAs), valvular heart disease, a...
Autores principales: | Sagar, Priyanka S., Rangan, Gopala K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577330/ https://www.ncbi.nlm.nih.gov/pubmed/37850017 http://dx.doi.org/10.1016/j.ekir.2023.07.017 |
Ejemplares similares
-
Polycystins, ADPKD, and Cardiovascular Disease
por: Kuo, Ivana Y., et al.
Publicado: (2019) -
Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
por: Au, Eric H.K., et al.
Publicado: (2022) -
Autosomal dominant polycystic kidney disease (ADPKD) is associated with coronary arterial dilatation in end-stage renal failure patients
por: Chiha, Joseph, et al.
Publicado: (2012) -
Clinical Characteristics of Rapid Progression in Asia-Pacific Patients With ADPKD
por: Oh, Yun Kyu, et al.
Publicado: (2023) -
Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD
por: Mallett, Andrew J., et al.
Publicado: (2021)